Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31156747 | 0.87 | ALDH1A1 (0.55) | ALDH1A1HIF1ALOXL2TDP1KDM4E | |
| SCHEMBL18041343 | 0.87 | ALDH1A1 (0.55) | ALDH1A1HIF1ALOXL2TDP1KDM4E | |
| SCHEMBL29673195 | 0.85 | ALDH1A1 (0.52) | ALDH1A1HIF1ALOXL2TDP1KMT2A | |
| SCHEMBL5001384 | 0.85 | ALDH1A1 (0.52) | ALDH1A1HIF1ALOXL2TDP1KMT2A | |
| Hydrochloric Acid SCHEMBL20766281 | 0.84 | ALDH1A1 (0.50) | ALDH1A1HIF1ALOXL2TDP1KMT2A | |
| SCHEMBL15076454 | 0.83 | ALDH1A1 (0.58) | ALDH1A1HIF1ATDP1KDM4EMEN1 | |
| SCHEMBL12955135 | 0.83 | ALDH1A1 (0.58) | ALDH1A1HIF1ATDP1MEN1MAPT | |
| SCHEMBL2062221 | 0.82 | LOXL2 (0.55) | ALDH1A1LOXL2TDP1KDM4EMEN1 | |
| SCHEMBL377336 | 0.81 | ALDH1A1 (0.56) | ALDH1A1HIF1AMEN1MAPTKMT2A | |
| SCHEMBL20560276 | 0.81 | ALDH1A1 (0.56) | ALDH1A1HIF1ATDP1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117603014-A | Meta-diamide compounds for controlling invertebrate pests | FMC公司 | 2024-02-27 | — | — | CN | disclosed |
| EP-4183766-A1 | INTERMEDIATES FOR THE PREPARATION OF META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC Corporation (US) | 2023-05-24 | — | — | EP | disclosed |
| EP-3887354-B1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC CORP (US) | 2023-01-04 | — | — | EP | disclosed |
| US-20210400977-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC CORPORATION | 2021-12-30 | — | — | US | disclosed |
| EP-3887354-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC Corporation (US) | 2021-10-06 | — | — | EP | disclosed |
| CN-113454065-A | Metadiamide compounds for controlling invertebrate pests | FMC公司 | 2021-09-28 | — | — | CN | disclosed |
| WO-2020112390-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC CORPORATION (US) | 2020-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210400977-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | DDT, RDX, ACHE | ALDH1A1 1035/4885HIF1A 2369/4885LOXL2 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.